145 related articles for article (PubMed ID: 38377731)
1. Pneumocystis jirovecii pneumonia presenting with severe, refractory hypercalcaemia in an immunosuppressed renal transplant patient: Review of the literature and novel biochemical insights.
Hong L; Witton LD; Jolly EC
Clin Med (Lond); 2024 Jan; 24(1):100011. PubMed ID: 38377731
[TBL] [Abstract][Full Text] [Related]
2. Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.
Yau AA; Farouk SS
BMC Infect Dis; 2019 Aug; 19(1):739. PubMed ID: 31438872
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcaemia preceding diagnosis of
Ling J; Anderson T; Warren S; Kirkland G; Jose M; Yu R; Yew S; Mcfadyen S; Graver A; Johnson W; Jeffs L
Clin Kidney J; 2017 Dec; 10(6):845-851. PubMed ID: 29225815
[TBL] [Abstract][Full Text] [Related]
4. A case of hypercalcemia from Pneumocystis jirovecii in an immunosuppressed non-HIV patient.
Gulhati V; Desy J; Thornton CS
BMC Pulm Med; 2024 Apr; 24(1):204. PubMed ID: 38658913
[TBL] [Abstract][Full Text] [Related]
5. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
[TBL] [Abstract][Full Text] [Related]
6. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
[TBL] [Abstract][Full Text] [Related]
7. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
[TBL] [Abstract][Full Text] [Related]
8. Clinical descriptive analysis of severe
Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y
Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387
[No Abstract] [Full Text] [Related]
9. Hypercalcemia associated with
Coche S; Cornet G; Morelle J; Labriola L; Kanaan N; Demoulin N
Acta Clin Belg; 2021 Feb; 76(1):75-78. PubMed ID: 31470765
[No Abstract] [Full Text] [Related]
10. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.
Peng J; Ni M; Du D; Lu Y; Song J; Liu W; Shen N; Wang X; Zhu Y; Vallance BA; Sun Z; Yu HB
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):83. PubMed ID: 34911528
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients.
Hamroun A; Lenain R; Bui Nguyen L; Chamley P; Loridant S; Neugebauer Y; Lionet A; Frimat M; Hazzan M
Sci Rep; 2019 Aug; 9(1):12508. PubMed ID: 31467367
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
[TBL] [Abstract][Full Text] [Related]
14. Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia.
Lian Q; Song X; Yang J; Wang L; Xu P; Wang X; Xu X; Yang B; He J; Ju C
Respir Res; 2024 Mar; 25(1):125. PubMed ID: 38486264
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcaemia as a prodromal feature of indolent Pneumocystis jivorecii after renal transplantation.
Bency R; Roger SD; Elder GJ
Nephrol Dial Transplant; 2011 May; 26(5):1740-2. PubMed ID: 21378150
[TBL] [Abstract][Full Text] [Related]
16. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
17. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
Yang P; Zhu X; Liang W; Cai R
Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
20. Acute Kidney Injury Secondary to Hypercalcemia in a Kidney Transplant Patient With Pneumocystis jirovecii Pneumonia: A Case Report.
Mascia G; Argiolas D; Carta E; Michittu MB; Piredda GB
Transplant Proc; 2019; 51(1):220-222. PubMed ID: 30736974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
